Beazer's underlying sales and margin performance has reflected increasing weakness. Read why I believe high caution is ...

Home healthcare provider Addus HomeCare (NASDAQ:ADUS) in Q1 CY2025, but sales rose 20.3% year on year to $337.7 million. Its ...

Ecolab's local-for-local strategy and pricing power effectively mitigate tariff impacts, but softness in heavy industrial ...

After two strong years, 2025 was expected to mark another high-growth chapter for the MedTech industry, particularly in ...

Even with its aggressive capex spending and ongoing support of the unprofitable Reality Labs division, Meta can still afford ...

The 55% decline in the stock from its 2021 high, combined with the company's consistent revenue growth since then, has pushed ...

Cera’s stock is down 40% from its peak, but profits are at record highs. With over Rs 600 crore cash, zero debt, and a Rs ...

Marico expects to sustain double-digit revenue growth and shall strive to deliver double-digit operating profit growth in ...